You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

15-038

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Worldwide (metastatic lesion biopsy)

Suspended
  • Metastatic Breast Cancer
  • metastatic lesion biopsy
  • Brussels, Belgium
  • +59 more
Jan 17, 2023

Diffuse Large B-cell Lymphoma Trial in Shanghai (GNC-038)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Dec 30, 2021

Spondyloarthritis Trial in Worldwide (Golimumab, Placebo)

Completed
  • Spondyloarthritis
  • Golimumab
  • Placebo
  • Brno, Czechia
  • +70 more
Jan 12, 2022

Non-hodgkin's Lymphoma Trial in Beijing (GNC-038)

Recruiting
  • Non-hodgkin's Lymphoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 12, 2023

NK/T Cell Lymphoma, Vascular Immunomother T Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Guangzhou (GNC-038)

Not yet recruiting
  • NK/T Cell Lymphoma
  • +2 more
  • Guangzhou, Guangdong, China
  • +1 more
Jan 12, 2023

Non-hodgkin Lymphoma Trial in Tianjin (GNC-038)

Recruiting
  • Non-hodgkin Lymphoma
  • Hefei, Anhui, China
  • +9 more
Jan 12, 2023

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Brisbane (ADX-038, Placebo)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane
May 17, 2023

Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive

Recruiting
  • Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
  • Hot Flashes
  • Elinzanetant (BAY3427080)
  • Placebo
  • Linz, Oberösterreich, Austria
  • +96 more
Jan 10, 2023

Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in Beijing (GNC-038)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 31, 2022

Chronic Cough Trial in Japan (Gefapixant, Placebo)

Completed
Has Results
  • Chronic Cough
  • Nagoya, Aichi, Japan
  • +60 more
Sep 30, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +107 more
Jul 11, 2022

Hereditary Angioedema Trial in Moscow (GNR-038, 25 ??/kg, GNR-038, 50 ??/kg, GNR-038, 100 ??/kg)

Completed
  • Hereditary Angioedema
  • GNR-038, 25 МЕ/kg
  • +2 more
  • Moscow, Russian Federation
    State budgetary institution of healthcare of the city of Moscow
Sep 28, 2020

Resistance to GNC-038 in Relapsed and Refractory Diffuse Large

Recruiting
  • Diffuse Large B Cell Lymphoma
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Apr 17, 2022

    Hereditary Angioedema Trial in Moscow, Rostov-on-Don, Stavropol' (GNR-038, 50 ??/ kg, GNR-038, 100 ??/ kg, Berinert®, 20 ??/ kg)

    Withdrawn
    • Hereditary Angioedema
    • GNR-038, 50 МЕ/ kg
    • +4 more
    • Moscow, Russian Federation
    • +4 more
    Jan 21, 2022

    Metastatic Breast Cancer Trial in New York (Brain radiotherapy or Stereotactic Radiosurgery, Tremelimumab, HER2 directed

    Completed
    Has Results
    • Metastatic Breast Cancer
    • Brain radiotherapy or Stereotactic Radiosurgery
    • +3 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Aug 2, 2022

    Nonsquamous NSCLC, EGFR L858R, EGFR Exon 19 Deletion Trial in Worldwide (Patritumab Deruxtecan, Platinum-based chemo)

    Recruiting
    • Nonsquamous Non-small Cell Lung Cancer
    • +2 more
    • Patritumab Deruxtecan
    • Platinum-based chemotherapy
    • Anchorage, Alaska
    • +182 more
    Jan 17, 2023

    Enhanced Recovery in Esophageal Surgery

    Completed
    • ERAS Protocol, Esophagectomy
    • Enhanced recovery program
    • Brussels, Belgium
      Cliniques universitaires Saint-Luc
    May 3, 2023

    Osteosarcoma, Osteosarcoma in Children, Osteosarcoma Recurrent Trial in United States (Regorafenib 40 MG, Regorafenib 20MG,

    Recruiting
    • Osteosarcoma
    • +3 more
    • Regorafenib 40 MG
    • +2 more
    • Los Angeles, California
    • +7 more
    Jan 19, 2023

    Cholelithiasis Trial in Guayaquil (LAMS placement for cholecystostomy, Laparoscopic cholecystectomy)

    Not yet recruiting
    • Cholelithiasis
    • LAMS placement for cholecystostomy
    • Laparoscopic cholecystectomy
    • Guayaquil, Guayas, Ecuador
      Instituto Ecuatoriano de Enfermedades Digestivas
    Sep 7, 2023

    Infertility Trial in Barcelona (Vaginal progesterone 600mg daily, Vaginal progesterone 800mg daily)

    Not yet recruiting
    • Infertility
    • Vaginal progesterone 600mg daily
    • Vaginal progesterone 800mg daily
    • Barcelona, Spain
      Hospital Universitario Quiron Dexeus
    Jun 1, 2023

    Bile Duct Diseases Trial in Sha Tin (EUS-guided rendezvous, Early precut papillotomy group)

    Recruiting
    • Bile Duct Diseases
    • EUS-guided rendezvous
    • Early precut papillotomy group
    • Sha Tin, New Territories, Hong Kong
      Prince of Wales Hospital, The Chinese University of Hong Kong
    Aug 23, 2023

    Healthy Male Volunteers Trial in Madison ([14C]-BMS-986196)

    Not yet recruiting
    • Healthy Male Volunteers
    • Madison, Wisconsin
    • +1 more
    Aug 1, 2023

    Dermal Allograft Augmentation of Large and Massive Rotator Cuff

    Not yet recruiting
    • Full-thickness Rotator Cuff Tear
    • Repair with DAA (dermal allograft augmentation)
    • (no location specified)
    Aug 1, 2023

    Acute Lymphocytic Leukemia, Lymphoma Trial in New York (Biological/Genetically Modified T cells, Cyclophosphamide-based chemo)

    Active, not recruiting
    • Acute Lymphocytic Leukemia
    • Lymphoma
    • Biological/Genetically Modified T cells
    • Cyclophosphamide-based chemotherapy
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 3, 2023

    Type 2 Diabetes, Obesity Trial in Worldwide (Tirzepatide, Placebo)

    Not yet recruiting
    • Type 2 Diabetes
    • Obesity
    • Caba, Buenos Aires, Argentina
    • +48 more
    Sep 8, 2023